ES2193379T3 - Combinacion de un analogo de somatostatina y de una rapamicina. - Google Patents

Combinacion de un analogo de somatostatina y de una rapamicina.

Info

Publication number
ES2193379T3
ES2193379T3 ES97928175T ES97928175T ES2193379T3 ES 2193379 T3 ES2193379 T3 ES 2193379T3 ES 97928175 T ES97928175 T ES 97928175T ES 97928175 T ES97928175 T ES 97928175T ES 2193379 T3 ES2193379 T3 ES 2193379T3
Authority
ES
Spain
Prior art keywords
combination
rapamycin
somatostatine
analog
prevention
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES97928175T
Other languages
English (en)
Inventor
Gisbert Weckbecker
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis Pharma GmbH
Novartis AG
Original Assignee
Novartis Pharma GmbH
Novartis AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9612171.0A external-priority patent/GB9612171D0/en
Priority claimed from GBGB9619310.7A external-priority patent/GB9619310D0/en
Application filed by Novartis Pharma GmbH, Novartis AG filed Critical Novartis Pharma GmbH
Application granted granted Critical
Publication of ES2193379T3 publication Critical patent/ES2193379T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/31—Somatostatins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Endocrinology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)

Abstract

UNA COMBINACION DE UN COMPUESTO DE CLASE SOMATOSTATINA Y MACROLIDO DE RAPAMICINA ES UTIL PARA LA PREVENCION O TRATAMIENTO DE HIPERPROLIFERACION DE CELULAS
ES97928175T 1996-06-11 1997-06-11 Combinacion de un analogo de somatostatina y de una rapamicina. Expired - Lifetime ES2193379T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9612171.0A GB9612171D0 (en) 1996-06-11 1996-06-11 Organic compounds
GBGB9619310.7A GB9619310D0 (en) 1996-09-16 1996-09-16 Organic compounds

Publications (1)

Publication Number Publication Date
ES2193379T3 true ES2193379T3 (es) 2003-11-01

Family

ID=26309485

Family Applications (1)

Application Number Title Priority Date Filing Date
ES97928175T Expired - Lifetime ES2193379T3 (es) 1996-06-11 1997-06-11 Combinacion de un analogo de somatostatina y de una rapamicina.

Country Status (10)

Country Link
US (1) US6362164B1 (es)
EP (1) EP0896544B1 (es)
JP (1) JP3784418B2 (es)
AT (1) ATE233098T1 (es)
AU (1) AU3257297A (es)
CA (1) CA2249439C (es)
DE (1) DE69719320T2 (es)
DK (1) DK0896544T3 (es)
ES (1) ES2193379T3 (es)
WO (1) WO1997047317A1 (es)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2304345T3 (es) 1999-03-29 2008-10-16 THE PROCTER & GAMBLE COMPANY Ligandos del receptor de melanocortina.
ES2167189B1 (es) * 1999-12-17 2003-04-01 Lipotec Sa Formulacion farmaceutica estable para la administracion intravenosa o intramuscular, de principios activos peptidicos
AU3095601A (en) * 2000-01-14 2001-07-24 Univ Pennsylvania O-methylated rapamycin derivatives for alleviation and inhibition of lymphoproliferative disorders
PT2762140T (pt) * 2001-02-19 2017-07-04 Novartis Ag Resumo
AU2005201004A1 (en) * 2001-02-19 2005-03-24 Novartis Ag Cancer treatment
AU2016206379B2 (en) * 2001-02-19 2017-09-14 Novartis Ag Cancer Treatment
AU2011226833B9 (en) * 2001-02-19 2014-07-03 Novartis Ag Cancer treatment
FI20031454A0 (fi) 2003-10-06 2003-10-06 Juvantia Pharma Ltd Oy Selektiivisiä somatostatiinireseptori 1 ja/tai 4 -agonisteja ja -antagonisteja
EP1522311A1 (fr) * 2003-10-10 2005-04-13 Institut National De La Sante Et De La Recherche Medicale (Inserm) Utilisation de la somatostine ou d'un de ses analogues pour préparer un médicament destiné à réguler la réserve folliculaire ovarienne chez la femme non ménopausée
CA2562164A1 (en) * 2004-04-27 2005-11-10 Wyeth Labeling of rapamycin using rapamycin-specific methylases
US20110104186A1 (en) 2004-06-24 2011-05-05 Nicholas Valiante Small molecule immunopotentiators and assays for their detection
ES2383303T3 (es) 2005-11-10 2012-06-20 Chemi S.P.A. Formulaciones de inhibidores de la liberación prolongada de la hormona del crecimiento análogos de la somatostatina
CA2933875C (en) 2005-11-21 2018-06-26 Novartis Ag 40-o-(2-hydroxyethyl)-rapamycin for use as a sole drug substance in the treatment of carcinoid tumors arising from the foregut, midgut, or hindgut
JP2009254391A (ja) * 2006-07-18 2009-11-05 Tetsuhiko Katsumata ゴルフのボールマーカー用ホルダー及びアクセサリー
RU2566484C2 (ru) 2010-07-29 2015-10-27 Линак А/С Подъемная колонна предпочтительно для регулируемых по высоте столов
EP2729008B1 (en) * 2011-07-07 2017-04-05 Research Cancer Institute of America Systems, methods, and formulations for treating cancer
US8933078B2 (en) 2011-07-14 2015-01-13 Research Cancer Institute Of America Method of treating cancer with combinations of histone deacetylase inhibitors (HDAC1) substances
WO2018157081A1 (en) 2017-02-27 2018-08-30 Research Cancer Institute Of America Compositions, methods, systems and/or kits for preventing and/or treating neoplasms
WO2018170457A1 (en) 2017-03-17 2018-09-20 Research Cancer Institute Of America Compositions, methods, systems and/or kits for preventing and/or treating neoplasms
JP7099717B2 (ja) 2019-09-30 2022-07-12 株式会社理研バイオ ソマトスタチン受容体

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2239178B (en) 1987-07-10 1991-11-27 Sandoz Ltd Somatostatin analogues for the treatment of breast cancer
GB9125660D0 (en) * 1991-12-03 1992-01-29 Smithkline Beecham Plc Novel compound

Also Published As

Publication number Publication date
EP0896544A1 (en) 1999-02-17
CA2249439C (en) 2009-09-08
DE69719320D1 (de) 2003-04-03
US6362164B1 (en) 2002-03-26
JP3784418B2 (ja) 2006-06-14
AU3257297A (en) 1998-01-07
DK0896544T3 (da) 2003-05-05
CA2249439A1 (en) 1997-12-18
JP2000514415A (ja) 2000-10-31
WO1997047317A1 (en) 1997-12-18
EP0896544B1 (en) 2003-02-26
ATE233098T1 (de) 2003-03-15
DE69719320T2 (de) 2003-12-11

Similar Documents

Publication Publication Date Title
ES2193379T3 (es) Combinacion de un analogo de somatostatina y de una rapamicina.
PT914103E (pt) Tratamento de uma hemoglobinopatia
GB9507862D0 (en) Fabrication of organic light-emitting devices
DE69636902D1 (de) Lactacystin-analoge
GB9509895D0 (en) Engaging structure of retainer
IL116724A0 (en) Substituted oxazolidine calpain and/or cathepsin B inhibitors
FI956339A (fi) Hypotalaamisen kuukautisten puuttumisen hoitaminen
FI953483A0 (fi) Jätekaasuöljyn käsittely
ES2186807T3 (es) Inhibidores de trombina.
DE69737718D1 (de) Nachweis von mikroorganismen
AU1750497A (en) Compounds capable of inhibiting hiv-1 infection
ID17472A (id) Sekat pencegah kebocoran
PL333366A1 (en) Arrangement of check valves
NO961619D0 (no) Spylekammer
AU1979397A (en) Peptidomimetics for the treatment of hiv infection
GB9222590D0 (en) The treatment of solid organic wastes
GB9403127D0 (en) The treatment of solid wastes
GB9424471D0 (en) Treatment of emesis
ATA149592A (de) Ringventil
KR970006285U (ko) 누수 방지용 볼트구조
KR970054685U (ko) 쓰레기통의 악취 제거장치
KR940019046U (ko) 마스킹 재
ZA968923B (en) The treatment of sewage
GB9218641D0 (en) Wells sewage treatment
SE9400471D0 (sv) En komponent bestående av fortsättnings möjligen en uppfattningskomponent el observeringskomponent